Zivo Bioscience Inc (ZIVO) - Net Assets

Latest as of March 2026: $-3.42 Million USD

Based on the latest financial reports, Zivo Bioscience Inc (ZIVO) has net assets worth $-3.42 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($516.78K) and total liabilities ($3.94 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Zivo Bioscience Inc (ZIVO) strategic asset index to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric	Value
Current Net Assets	$-3.42 Million
% of Total Assets	-662.65%
Annual Growth Rate	N/A
5-Year Change	-162.03%
10-Year Change	N/A
Growth Volatility	N/A

Zivo Bioscience Inc - Net Assets Trend (2003–2025)

This chart illustrates how Zivo Bioscience Inc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see ZIVO market cap.

Annual Net Assets for Zivo Bioscience Inc (2003–2025)

The table below shows the annual net assets of Zivo Bioscience Inc from 2003 to 2025. Also explore net asset growth rate of Zivo Bioscience Inc to track the company's year-over-year net asset growth rate.

Year	Net Assets	Change
2025-12-31	$-3.75 Million	-627.91%
2024-12-31	$-514.90K	+76.66%
2023-12-31	$-2.21 Million	-20666.74%
2022-12-31	$-10.62K	-100.18%
2021-12-31	$6.04 Million	+153.42%
2020-12-31	$-11.31 Million	-35.64%
2019-12-31	$-8.34 Million	+62.58%
2018-12-31	$-22.28 Million	-36.66%
2017-12-31	$-16.30 Million	-19.70%
2016-12-31	$-13.62 Million	-43.43%
2015-12-31	$-9.50 Million	-49.11%
2014-12-31	$-6.37 Million	+33.61%
2013-12-31	$-9.59 Million	-142.50%
2012-12-31	$-3.96 Million	-94.74%
2011-12-31	$-2.03 Million	-113.46%
2010-12-31	$-951.68K	+74.86%
2009-12-31	$-3.79 Million	-628.57%
2008-12-31	$-519.60K	+31.21%
2007-12-31	$-755.37K	+9.27%
2006-12-31	$-832.54K	-41.09%
2005-12-31	$-590.09K	+46.48%
2004-12-31	$-1.10 Million	-2968.34%
2003-12-31	$-35.94K	--

Equity Component Analysis

This analysis shows how different components contribute to Zivo Bioscience Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 14681450900.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Common Stock	$3.95K	%
Other Components	$143.11 Million	%
Total Equity	$-3.75 Million	100.00%

Zivo Bioscience Inc Competitors by Market Cap

The table below lists competitors of Zivo Bioscience Inc ranked by their market capitalization.

Company	Market Cap
Cherry AG XETRA:C3RY	$14.61 Million
Fat Prophets Global Property Fund AU:FPP	$14.61 Million
Talius Group Ltd. AU:TAL	$14.62 Million
ABERA BIOSCIENCE AB F:8WK	$14.62 Million
EV Nickel Inc V:EVNI	$14.59 Million
Orege Société Anonyme PA:OREGE	$14.58 Million
BBI Development S.A. WAR:BBD	$14.58 Million
Bertam Alliance Bhd KLSE:9814	$14.58 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Zivo Bioscience Inc's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from -514,897 to -3,748,011, a change of -3,233,114.
Net loss of 9,892,305 reduced equity.
Other factors increased equity by 6,659,191.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	$-9.89 Million	-263.93%
Other Changes	$6.66 Million	+177.67%
Total Change	$-	%

Book Value vs Market Value Analysis

This analysis compares Zivo Bioscience Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2000-12-31	$-0.17	$3.52	x
2003-12-31	$-0.30	$3.52	x
2004-12-31	$-7.75	$3.52	x
2005-12-31	$-2.59	$3.52	x
2006-12-31	$-1.94	$3.52	x
2007-12-31	$-1.43	$3.52	x
2008-12-31	$-0.79	$3.52	x
2009-12-31	$-4.11	$3.52	x
2010-12-31	$-0.87	$3.52	x
2011-12-31	$-1.68	$3.52	x
2012-12-31	$-18.73	$3.52	x
2013-12-31	$-41.04	$3.52	x
2014-12-31	$-16.78	$3.52	x
2015-12-31	$-34.81	$3.52	x
2016-12-31	$-48.85	$3.52	x
2017-12-31	$-56.20	$3.52	x
2018-12-31	$-68.26	$3.52	x
2019-12-31	$-14.48	$3.52	x
2020-12-31	$-13.37	$3.52	x
2021-12-31	$4.75	$3.52	x
2022-12-31	$-0.01	$3.52	x
2023-12-31	$-1.31	$3.52	x
2024-12-31	$-0.15	$3.52	x
2025-12-31	$-0.98	$3.52	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Zivo Bioscience Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 0.00%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -8311.12%
• Asset Turnover: 0.18x
• Equity Multiplier: 0.00x
Recent ROE (0.00%) is above the historical average (-6.48%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2000	0.00%	0.00%	0.00x	0.00x	$-3.45K
2003	0.00%	-32191.49%	0.17x	0.00x	$-537.22K
2004	0.00%	-7866.21%	0.92x	0.00x	$-3.75 Million
2005	0.00%	-6207.23%	0.15x	0.00x	$-5.90 Million
2006	0.00%	-1191.15%	0.92x	0.00x	$-3.46 Million
2007	0.00%	-1395.18%	0.59x	0.00x	$-2.18 Million
2008	0.00%	-1025.33%	0.41x	0.00x	$-1.76 Million
2009	0.00%	-1790.32%	0.20x	0.00x	$-1.04 Million
2010	0.00%	-8609.82%	0.24x	0.00x	$-7.03 Million
2011	0.00%	-2629.30%	0.22x	0.00x	$-2.53 Million
2012	0.00%	0.00%	0.00x	0.00x	$-2.85 Million
2013	0.00%	-3841.12%	0.12x	0.00x	$-9.14 Million
2014	0.00%	0.00%	0.00x	0.00x	$1.32 Million
2015	0.00%	0.00%	0.00x	0.00x	$-4.84 Million
2016	0.00%	0.00%	0.00x	0.00x	$-4.70 Million
2017	0.00%	0.00%	0.00x	0.00x	$-8.41 Million
2018	0.00%	0.00%	0.00x	0.00x	$-12.41 Million
2019	0.00%	-73339.91%	0.05x	0.00x	$-13.83 Million
2020	0.00%	-48278.92%	0.09x	0.00x	$-8.52 Million
2021	-155.52%	0.00%	0.00x	1.49x	$-10.00 Million
2022	0.00%	-215933.16%	0.00x	0.00x	$-8.74 Million
2023	0.00%	-28127.25%	0.05x	0.00x	$-7.56 Million
2024	0.00%	-8513.44%	0.10x	0.00x	$-13.33 Million
2025	0.00%	-8311.12%	0.18x	0.00x	$-9.52 Million

Industry Comparison

This section compares Zivo Bioscience Inc's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $201,571,196
Average return on equity (ROE) among peers: -90.19%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Zivo Bioscience Inc (ZIVO)	$-3.42 Million	0.00%	N/A	$14.59 Million
Aardvark Therapeutics, Inc. Common Stock (AARD)	$-34.80 Million	0.00%	0.00x	$112.13 Million
Abcellera Biologics Inc (ABCL)	$1.03 Billion	-0.22%	0.29x	$2.99 Billion
Abeona Therapeutics Inc (ABEO)	$44.03 Million	-144.75%	1.47x	$307.08 Million
Acumen Pharmaceuticals Inc (ABOS)	$225.18 Million	-44.68%	0.02x	$155.29 Million
Abpro Holdings, Inc. (ABP)	$-85.14 Million	0.00%	0.00x	$2.00 Million
Absci Corp (ABSI)	$-41.16 Million	0.00%	0.00x	$1.36 Billion
Arbutus Biopharma Corp (ABUS)	$76.58 Million	-43.75%	0.24x	$906.70 Million
ABVC Biopharma Inc (ABVC)	$723.96K	-677.23%	9.41x	$28.25 Million
Abivax SA American Depositary Shares (ABVX)	$71.77 Million	-22.23%	0.06x	$8.92 Billion
ACADIA Pharmaceuticals Inc (ACAD)	$732.79 Million	30.90%	0.62x	$4.75 Billion

About Zivo Bioscience Inc

NASDAQ:ZIVO USA Biotechnology

Market Cap

$14.59 Million

Market Cap Rank

#26153 Global

#5467 in USA

Share Price

$3.52

Change (1 day)

-14.27%

52-Week Range

$1.17 - $17.00

All Time High

$32.70